|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000366930
|
TGFB2
|
NA
|
Withaferin A
|
kidney injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
Cimifugin
|
fibrotic cataracts
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
NA
|
salivary adenoid cystic carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
Lactacystin
|
renal interstitial fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
MG132
|
renal interstitial fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB00877
|
Sirolimus
|
chronic kidney disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB01611
|
Hydroxychloroquine
|
oral lichen planus
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB02709
|
Resveratrol
|
renal fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
Recombinant Leishmania donovani TPR
|
visceral leishmaniasis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
Dibenzazepine
|
kidney fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB08868
|
Fingolimod
|
paraquat poisoning
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB12297
|
GLPG-0187
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB06209
|
Prasugrel
|
fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB06209
|
Prasugrel
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB00331
|
Metformin
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
SB.334867
|
experimental autoimmune encephalomyelitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
Conophylline
|
hepatic inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
Conophylline
|
hepatic steatosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
Conophylline
|
non alcoholic steatohepatitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
Conophylline
|
hepatic fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB09030
|
Vorapaxar
|
idiopathic pulmonary fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
Sini decoction
|
colorectal cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB18007
|
Dersimelagon
|
systemic sclerosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
ligustrazine
|
biliary atresia
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB00945
|
Aspirin
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
Agnuside
|
knee osteoarthritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB01137
|
Levofloxacin
|
hepatopulmonary syndrome
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
NA
|
Tea polyphenol
|
hepatopulmonary syndrome
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB00864
|
Tacrolimus
|
asthma
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB00864
|
Tacrolimus
|
allergic disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB14152
|
Ginsenosides
|
hepatic fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000366930
|
TGFB2
|
DB04951
|
Pirfenidone
|
glioma
|
down-regulated
|
validated
|
more...
|